Succinylsulfathiazole: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
No edit summary
 
Line 1: Line 1:
{{Drugbox
{{Drugbox
| IUPAC_name       = 4-Oxo-4-[ [4-(1,3-thiazol-2-ylsulfamoyl)phenyl]amino]butanoic acid
| Watchedfields = changed
| image             = Succinylsulfathiazole.png
| verifiedrevid = 443214593
| CAS_number        =
| IUPAC_name = 4-oxo-4-({4-[(1,3-thiazol-2-ylamino)sulfonyl]phenyl}amino)butanoic acid
| ATC_prefix        = A07
| image = Succinylsulfathiazole.png
| ATC_suffix        = AB04
 
| PubChem          = 5315
<!--Clinical data-->
| DrugBank          =
| tradename =   
| C=13|H=13|N=3|O=5|S=2
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| molecular_weight = 355.38942 g/mol
| pregnancy_US = <!-- A / B            / C / D / X -->
| bioavailability  =
| pregnancy_category =   
| protein_bound    =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| metabolism        =
| legal_CA = <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
| elimination_half-life =
| legal_UK = <!-- GSL        / P      / POM / CD / Class A, B, C -->
| excretion        =
| legal_US = <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| pregnancy_AU     = <!-- A / B1 / B2 / B3 / C / D / X -->
| legal_status =
| pregnancy_US     = <!-- A / B            / C / D / X -->
| routes_of_administration =
| pregnancy_category=   
 
| legal_AU         = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
<!--Pharmacokinetic data-->
| legal_CA         = <!--            / Schedule I, II, III, IV, V, VI, VII, VIII -->
| bioavailability = 
| legal_UK         = <!-- GSL        / P      / POM / CD / Class A, B, C -->
| protein_bound = 
| legal_US         = <!-- OTC                  / Rx-only  / Schedule I, II, III, IV, V -->
| metabolism = 
| legal_status     =  
| elimination_half-life = 
| routes_of_administration =  
| excretion = 
 
<!--Identifiers-->
| CAS_number = 
| ATC_prefix = A07
| ATC_suffix = AB04
| PubChem = 5315
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChEMBL = 1484857
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = RSS8647O4S
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07060
 
<!--Chemical data-->
| C=13 | H=13 | N=3 | O=5 | S=2
| molecular_weight = 355.38942 g/mol
}}
}}


'''Succinylsulfathiazole''' is a [[Sulfonamide (medicine)|sulfonamide]]. It is also spelled as succinylsulphathiazole. It is a white or yellow-white crystalline powder. It dissolves in aqueous solutions of alkali hydroxides and carbonates but is very slightly soluble in water.


'''Succinylsulfathiazole''' is a [[Sulfonamide (medicine)|sulfonamide]].
It is classified as ultra long acting drug. About 95% of the drug remains in the intestine and only 5% is hydrolyzed, slowly, to [[Sulfathiazole]] and is absorbed.
 
The drug is used for its antibacterial activity in the GIT. The dose is 10g - 20g daily in divided doses.




{{pharma-stub}}


{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}
{{Antidiarrheals, intestinal anti-inflammatory/anti-infective agents}}


[[Category:Sulfonamides]]
[[Category:Thiazoles]]
[[Category:Thiazoles]]
 
[[Category:Sulfonamide antibiotics]]
{{WikiDoc Help Menu}}
[[Category:Anilides]]
{{WS}}

Latest revision as of 19:06, 7 April 2015

Succinylsulfathiazole
Clinical data
ATC code
Identifiers
PubChem CID
UNII
KEGG
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC13H13N3O5S2
Molar mass355.38942 g/mol
  (verify)

Succinylsulfathiazole is a sulfonamide. It is also spelled as succinylsulphathiazole. It is a white or yellow-white crystalline powder. It dissolves in aqueous solutions of alkali hydroxides and carbonates but is very slightly soluble in water.

It is classified as ultra long acting drug. About 95% of the drug remains in the intestine and only 5% is hydrolyzed, slowly, to Sulfathiazole and is absorbed.

The drug is used for its antibacterial activity in the GIT. The dose is 10g - 20g daily in divided doses.


Template:Antidiarrheals, intestinal anti-inflammatory/anti-infective agents